Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancer

Cancer immunology research

Volumn 2, Issue 1, 2014, Pages 37-49

  Odunsi, Kunle ^a   Matsuzaki, Junko ^a   James, Smitha R ^a   Mhawech Fauceglia, Paulette ^a   Tsuji, Takemasa ^a   Miller, Austin ^a   Zhang, Wa ^a   Akers, Stacey N ^a   Griffiths, Elizabeth A ^a   Miliotto, Anthony ^a   Beck, Amy ^a   Batt, Carl A ^a   Ritter, Gerd ^a   Lele, Shashikant ^a   Gnjatic, Sacha ^a   Karpf, Adam R ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AZACITIDINE; CANCER VACCINE; CTAG1B PROTEIN, HUMAN; DECITABINE; DOXORUBICIN; MACROGOL DERIVATIVE; MEMBRANE PROTEIN; TUMOR ANTIGEN;

ACTIVE IMMUNIZATION; ADULT; AGED; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; DNA METHYLATION; DRUG EFFECTS; FEMALE; GENE EXPRESSION; GENETIC EPIGENESIS; GENETICS; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGY; LONG INTERSPERSED REPEAT; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PATHOLOGY; PHASE 1 CLINICAL TRIAL; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME; TUMOR CELL LINE; TUMOR RECURRENCE;

ADULT; AGED; ANTIGENS, NEOPLASM; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AZACITIDINE; CANCER VACCINES; CELL LINE, TUMOR; DNA METHYLATION; DOXORUBICIN; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION; HUMANS; IMMUNITY, HUMORAL; IMMUNOTHERAPY, ACTIVE; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; POLYETHYLENE GLYCOLS; T-LYMPHOCYTE SUBSETS; TREATMENT OUTCOME;

EID: 84894106057     PISSN: None     EISSN: 23266074     Source Type: Journal    
DOI: 10.1158/2326-6066.CIR-13-0126     Document Type: Article

References (0)